Tamoxifen (TMX) therapy and hormone replacement therapy (HRT) are the two core regimens for hormone therapy in HCC (Meng and Liu, 2022).Although the efficacy of TMX in HCC remains controversial, there are still relevant studies reporting a positive relationship between the cancer inhibitory effect of TMX and ERα expression levels. The gene discussed is ESR1; the disease is hepatocellular carcinoma.